Daniel E. Morse
Corporate Officer/Principal en University of California, Santa Barbara .
Cargos activos de Daniel E. Morse
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of California, Santa Barbara | Corporate Officer/Principal | 01/01/1973 | - |
Historial de carrera de Daniel E. Morse
Antiguos cargos conocidos de Daniel E. Morse.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Director/Miembro de la Junta | 09/04/2010 | 28/09/2018 |
Independent Dir/Board Member | 09/04/2010 | 28/09/2018 | |
Stellar Biotechnologies, Inc. /Old/ | Director Técnico/Científico/I+D | 19/04/2010 | 01/12/2011 |
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Director/Miembro de la Junta | 20/04/2010 | 20/04/2010 |
Corporate Officer/Principal | 20/04/2010 | 20/04/2010 | |
SBA Materials, Inc.
SBA Materials, Inc. Electronic Production EquipmentElectronic Technology SBA Materials, Inc. develops engineered nano-structured materials. It engages in the development and commercialization of advanced electronic materials for back-end of line and packaging applications for semiconductor manufacturing. The firm has advanced electronic materials to address unmet needs of today's and tomorrow's electronic device manufacturers. The company was founded by Bradley F. Chmelka, William E. Cook, Daniel E. Morse and Galen D. Stucky in 2001 and is headquartered in San Jose, CA. | Fundador | 21/07/2010 | - |
Formación de Daniel E. Morse.
Harvard University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Canadá | 3 |
Operativa
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Finance |
Stellar Biotechnologies, Inc. /Old/ | Health Technology |
SBA Materials, Inc.
SBA Materials, Inc. Electronic Production EquipmentElectronic Technology SBA Materials, Inc. develops engineered nano-structured materials. It engages in the development and commercialization of advanced electronic materials for back-end of line and packaging applications for semiconductor manufacturing. The firm has advanced electronic materials to address unmet needs of today's and tomorrow's electronic device manufacturers. The company was founded by Bradley F. Chmelka, William E. Cook, Daniel E. Morse and Galen D. Stucky in 2001 and is headquartered in San Jose, CA. | Electronic Technology |
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel E. Morse
- Experiencia